β-Alanine  ||| S:0 E:10 ||| NNP
does  ||| S:10 E:15 ||| VBZ
not  ||| S:15 E:19 ||| RB
act  ||| S:19 E:23 ||| VB
through  ||| S:23 E:31 ||| IN
branched-chain  ||| S:31 E:46 ||| JJ
amino  ||| S:46 E:52 ||| JJ
acid  ||| S:52 E:57 ||| NN
catabolism  ||| S:57 E:68 ||| NN
in  ||| S:68 E:71 ||| IN
carp ||| S:71 E:75 ||| NN
,  ||| S:75 E:77 ||| ,
a  ||| S:77 E:79 ||| DT
species  ||| S:79 E:87 ||| NN
with  ||| S:87 E:92 ||| IN
low  ||| S:92 E:96 ||| JJ
muscular  ||| S:96 E:105 ||| JJ
carnosine  ||| S:105 E:115 ||| JJ
storage  ||| S:115 E:123 ||| NN
This  ||| S:123 E:128 ||| DT
study  ||| S:128 E:134 ||| NN
was  ||| S:134 E:138 ||| VBD
executed  ||| S:138 E:147 ||| VBN
to  ||| S:147 E:150 ||| TO
investigate  ||| S:150 E:162 ||| VB
the  ||| S:162 E:166 ||| DT
effect  ||| S:166 E:173 ||| NN
of  ||| S:173 E:176 ||| IN
dietary  ||| S:176 E:184 ||| JJ
β-alanine  ||| S:184 E:194 ||| NN
( ||| S:194 E:195 ||| -LRB-
BA ||| S:195 E:197 ||| NNP
)  ||| S:197 E:199 ||| -RRB-
on  ||| S:199 E:202 ||| IN
amino  ||| S:202 E:208 ||| JJ
acid  ||| S:208 E:213 ||| NN
( ||| S:213 E:214 ||| -LRB-
AA ||| S:214 E:216 ||| NN
)  ||| S:216 E:218 ||| -RRB-
metabolism  ||| S:218 E:229 ||| NN
and  ||| S:229 E:233 ||| CC
voluntary  ||| S:233 E:243 ||| JJ
feed  ||| S:243 E:248 ||| NN
intake  ||| S:248 E:255 ||| NN
in  ||| S:255 E:258 ||| IN
carp  ||| S:258 E:263 ||| NNS
( ||| S:263 E:264 ||| -LRB-
Cyprinus  ||| S:264 E:273 ||| UH
carpio ||| S:273 E:279 ||| UH
)  ||| S:279 E:281 ||| -RRB-
at  ||| S:281 E:284 ||| IN
mildly  ||| S:284 E:291 ||| RB
elevated  ||| S:291 E:300 ||| JJ
temperature  ||| S:300 E:312 ||| NN
to  ||| S:312 E:315 ||| TO
exert  ||| S:315 E:321 ||| VB
AA  ||| S:321 E:324 ||| NN
catabolism ||| S:324 E:334 ||| NN
.  ||| S:334 E:336 ||| .
Twenty-four  ||| S:336 E:348 ||| CD
fish  ||| S:348 E:353 ||| NN
in  ||| S:353 E:356 ||| IN
12  ||| S:356 E:359 ||| CD
aquaria  ||| S:359 E:367 ||| NNS
were  ||| S:367 E:372 ||| VBD
randomly  ||| S:372 E:381 ||| RB
assigned  ||| S:381 E:390 ||| VBN
to  ||| S:390 E:393 ||| TO
either  ||| S:393 E:400 ||| VB
a  ||| S:400 E:402 ||| DT
control  ||| S:402 E:410 ||| NN
diet  ||| S:410 E:415 ||| NN
or  ||| S:415 E:418 ||| CC
the  ||| S:418 E:422 ||| DT
same  ||| S:422 E:427 ||| JJ
diet  ||| S:427 E:432 ||| NN
with  ||| S:432 E:437 ||| IN
500  ||| S:437 E:441 ||| CD
mg  ||| S:441 E:444 ||| FW
BA ||| S:444 E:446 ||| FW
/ ||| S:446 E:447 ||| FW
kg ||| S:447 E:449 ||| FW
.  ||| S:449 E:451 ||| .
A  ||| S:451 E:453 ||| DT
14-day  ||| S:453 E:460 ||| JJ
period  ||| S:460 E:467 ||| NN
at  ||| S:467 E:470 ||| IN
an  ||| S:470 E:473 ||| DT
ideal  ||| S:473 E:479 ||| JJ
temperature  ||| S:479 E:491 ||| NN
( ||| S:491 E:492 ||| -LRB-
23  ||| S:492 E:495 ||| CD
°C ||| S:495 E:497 ||| CD
)  ||| S:497 E:499 ||| -RRB-
was  ||| S:499 E:503 ||| VBD
followed  ||| S:503 E:512 ||| VBN
by  ||| S:512 E:515 ||| IN
15  ||| S:515 E:518 ||| CD
days  ||| S:518 E:523 ||| NNS
at  ||| S:523 E:526 ||| IN
chronic  ||| S:526 E:534 ||| FW
mildly  ||| S:534 E:541 ||| FW
elevated  ||| S:541 E:550 ||| FW
temperature  ||| S:550 E:562 ||| FW
( ||| S:562 E:563 ||| -LRB-
27  ||| S:563 E:566 ||| CD
°C ||| S:566 E:568 ||| CD
) ||| S:568 E:569 ||| -RRB-
.  ||| S:569 E:571 ||| .
After  ||| S:571 E:577 ||| IN
the  ||| S:577 E:581 ||| DT
15  ||| S:581 E:584 ||| CD
days ||| S:584 E:588 ||| NNS
,  ||| S:588 E:590 ||| ,
all  ||| S:590 E:594 ||| DT
fish  ||| S:594 E:599 ||| NN
were  ||| S:599 E:604 ||| VBD
euthanised  ||| S:604 E:615 ||| VBN
for  ||| S:615 E:619 ||| IN
muscle  ||| S:619 E:626 ||| NN
analysis  ||| S:626 E:635 ||| NN
on  ||| S:635 E:638 ||| IN
histidine-containing  ||| S:638 E:659 ||| JJ
dipeptides  ||| S:659 E:670 ||| NNS
( ||| S:670 E:671 ||| -LRB-
HCD ||| S:671 E:674 ||| NNP
) ||| S:674 E:675 ||| -RRB-
,  ||| S:675 E:677 ||| ,
whole  ||| S:677 E:683 ||| JJ
blood  ||| S:683 E:689 ||| NN
on  ||| S:689 E:692 ||| IN
free  ||| S:692 E:697 ||| JJ
AA  ||| S:697 E:700 ||| NN
and  ||| S:700 E:704 ||| CC
carnitine  ||| S:704 E:714 ||| JJ
esters ||| S:714 E:720 ||| NN
.  ||| S:720 E:722 ||| .
The  ||| S:722 E:726 ||| DT
carnosine  ||| S:726 E:736 ||| NN
and  ||| S:736 E:740 ||| CC
anserine  ||| S:740 E:749 ||| JJ
analysis  ||| S:749 E:758 ||| NN
indicated  ||| S:758 E:768 ||| VBD
that  ||| S:768 E:773 ||| IN
all  ||| S:773 E:777 ||| DT
analyses  ||| S:777 E:786 ||| NNS
were  ||| S:786 E:791 ||| VBD
below  ||| S:791 E:797 ||| IN
the  ||| S:797 E:801 ||| DT
detection  ||| S:801 E:811 ||| JJ
limit  ||| S:811 E:817 ||| NN
of  ||| S:817 E:820 ||| IN
5  ||| S:820 E:822 ||| CD
µmol ||| S:822 E:826 ||| CD
/ ||| S:826 E:827 ||| CD
L ||| S:827 E:828 ||| NNP
,  ||| S:828 E:830 ||| ,
confirming  ||| S:830 E:841 ||| VBG
that  ||| S:841 E:846 ||| DT
carp  ||| S:846 E:851 ||| NN
belongs  ||| S:851 E:859 ||| VBZ
to  ||| S:859 E:862 ||| TO
a  ||| S:862 E:864 ||| DT
species  ||| S:864 E:872 ||| NNS
that  ||| S:872 E:877 ||| WDT
does  ||| S:877 E:882 ||| VBZ
not  ||| S:882 E:886 ||| RB
store  ||| S:886 E:892 ||| VB
HCD ||| S:892 E:895 ||| NNP
.  ||| S:895 E:897 ||| .
The  ||| S:897 E:901 ||| DT
increases  ||| S:901 E:911 ||| NNS
in  ||| S:911 E:914 ||| IN
free  ||| S:914 E:919 ||| JJ
AA  ||| S:919 E:922 ||| NN
concentrations  ||| S:922 E:937 ||| NNS
due  ||| S:937 E:941 ||| JJ
to  ||| S:941 E:944 ||| TO
BA  ||| S:944 E:947 ||| NNP
supplementation  ||| S:947 E:963 ||| VBD
failed  ||| S:963 E:970 ||| VBN
to  ||| S:970 E:973 ||| TO
reach  ||| S:973 E:979 ||| VB
the  ||| S:979 E:983 ||| DT
level  ||| S:983 E:989 ||| NN
of  ||| S:989 E:992 ||| IN
significance ||| S:992 E:1004 ||| NN
.  ||| S:1004 E:1006 ||| .
The  ||| S:1006 E:1010 ||| DT
effects  ||| S:1010 E:1018 ||| NNS
of  ||| S:1018 E:1021 ||| IN
dietary  ||| S:1021 E:1029 ||| JJ
BA  ||| S:1029 E:1032 ||| NN
on  ||| S:1032 E:1035 ||| IN
selected  ||| S:1035 E:1044 ||| JJ
whole  ||| S:1044 E:1050 ||| JJ
blood  ||| S:1050 E:1056 ||| NN
carnitine  ||| S:1056 E:1066 ||| NN
esters  ||| S:1066 E:1073 ||| NNS
and  ||| S:1073 E:1077 ||| CC
their  ||| S:1077 E:1083 ||| PRP$
ratios  ||| S:1083 E:1090 ||| NNS
were  ||| S:1090 E:1095 ||| VBD
also  ||| S:1095 E:1100 ||| RB
not  ||| S:1100 E:1104 ||| RB
significant ||| S:1104 E:1115 ||| JJ
.  ||| S:1115 E:1117 ||| .
The  ||| S:1117 E:1121 ||| DT
supplementation  ||| S:1121 E:1137 ||| NN
of  ||| S:1137 E:1140 ||| IN
BA  ||| S:1140 E:1143 ||| NNP
tended  ||| S:1143 E:1150 ||| VBD
to  ||| S:1150 E:1153 ||| TO
increase  ||| S:1153 E:1162 ||| VB
body  ||| S:1162 E:1167 ||| NN
weight  ||| S:1167 E:1174 ||| NN
gain  ||| S:1174 E:1179 ||| NN
( ||| S:1179 E:1180 ||| -LRB-
P  ||| S:1180 E:1182 ||| NN
=  ||| S:1182 E:1184 ||| SYM
0.081 ||| S:1184 E:1189 ||| CD
)  ||| S:1189 E:1191 ||| -RRB-
and  ||| S:1191 E:1195 ||| CC
feed  ||| S:1195 E:1200 ||| NN
intake  ||| S:1200 E:1207 ||| NNS
( ||| S:1207 E:1208 ||| -LRB-
P  ||| S:1208 E:1210 ||| NN
=  ||| S:1210 E:1212 ||| SYM
0.092 ||| S:1212 E:1217 ||| CD
) ||| S:1217 E:1218 ||| -RRB-
.  ||| S:1218 E:1220 ||| .
The  ||| S:1220 E:1224 ||| DT
lack  ||| S:1224 E:1229 ||| NN
of  ||| S:1229 E:1232 ||| IN
differences  ||| S:1232 E:1244 ||| NNS
in  ||| S:1244 E:1247 ||| IN
the  ||| S:1247 E:1251 ||| DT
selected  ||| S:1251 E:1260 ||| JJ
nutrient  ||| S:1260 E:1269 ||| JJ
metabolites  ||| S:1269 E:1281 ||| NN
in  ||| S:1281 E:1284 ||| IN
combination  ||| S:1284 E:1296 ||| NN
with  ||| S:1296 E:1301 ||| IN
tendencies  ||| S:1301 E:1312 ||| NNS
of  ||| S:1312 E:1315 ||| IN
improved  ||| S:1315 E:1324 ||| JJ
growth  ||| S:1324 E:1331 ||| NN
performance  ||| S:1331 E:1343 ||| NN
warrants  ||| S:1343 E:1352 ||| NNS
further  ||| S:1352 E:1360 ||| JJ
investigation  ||| S:1360 E:1374 ||| NN
to  ||| S:1374 E:1377 ||| TO
unravel  ||| S:1377 E:1385 ||| VB
the  ||| S:1385 E:1389 ||| DT
mechanism  ||| S:1389 E:1399 ||| NN
of  ||| S:1399 E:1402 ||| IN
BA  ||| S:1402 E:1405 ||| NNP
affecting  ||| S:1405 E:1415 ||| VBG
feed  ||| S:1415 E:1420 ||| NN
intake ||| S:1420 E:1426 ||| NN
.  ||| S:1426 E:1428 ||| .
This  ||| S:1428 E:1433 ||| DT
first  ||| S:1433 E:1439 ||| JJ
trial  ||| S:1439 E:1445 ||| NN
on  ||| S:1445 E:1448 ||| IN
the  ||| S:1448 E:1452 ||| DT
effect  ||| S:1452 E:1459 ||| NN
of  ||| S:1459 E:1462 ||| IN
BA  ||| S:1462 E:1465 ||| NNP
supplementation  ||| S:1465 E:1481 ||| NN
on  ||| S:1481 E:1484 ||| IN
AA  ||| S:1484 E:1487 ||| NN
catabolism  ||| S:1487 E:1498 ||| NNS
showed  ||| S:1498 E:1505 ||| VBD
that  ||| S:1505 E:1510 ||| IN
its  ||| S:1510 E:1514 ||| PRP$
metabolic  ||| S:1514 E:1524 ||| JJ
effect  ||| S:1524 E:1531 ||| NN
in  ||| S:1531 E:1534 ||| IN
carp  ||| S:1534 E:1539 ||| NN
at  ||| S:1539 E:1542 ||| IN
chronic  ||| S:1542 E:1550 ||| NN
mildly  ||| S:1550 E:1557 ||| RB
elevated  ||| S:1557 E:1566 ||| JJ
temperature  ||| S:1566 E:1578 ||| NN
was  ||| S:1578 E:1582 ||| VBD
very  ||| S:1582 E:1587 ||| RB
limited ||| S:1587 E:1594 ||| VBN
.  ||| S:1594 E:1596 ||| .
Further  ||| S:1596 E:1604 ||| JJ
studies  ||| S:1604 E:1612 ||| NNS
need  ||| S:1612 E:1617 ||| VBP
to  ||| S:1617 E:1620 ||| TO
evaluate  ||| S:1620 E:1629 ||| VB
which  ||| S:1629 E:1635 ||| WDT
conditions  ||| S:1635 E:1646 ||| NNS
are  ||| S:1646 E:1650 ||| VBP
able  ||| S:1650 E:1655 ||| JJ
to  ||| S:1655 E:1658 ||| TO
exert  ||| S:1658 E:1664 ||| VB
an  ||| S:1664 E:1667 ||| DT
effect  ||| S:1667 E:1674 ||| NN
of  ||| S:1674 E:1677 ||| IN
BA  ||| S:1677 E:1680 ||| NNP
on  ||| S:1680 E:1683 ||| IN
AA  ||| S:1683 E:1686 ||| NN
metabolism ||| S:1686 E:1696 ||| NN
.  ||| S:1696 E:1698 ||| .
